AiVF Raises $25M in Series A Funding

AiVF$25m in Series A funding has been raised for a Tel Aviv, Israel-based company that develops medical technology.

The round was led by Insight Partners with participation from Adam Neumann’s Family Office, 166 2nd.

The company will use the funding to accelerate adoption of its AI platform, EMA™ in the United States and Europe, expand its workforce and develop additional solutions to drive a new generation of digital fertility care.

Daniella Gilboa (co-founder, CEO, clinical embryologist) and Prof. Daniel Seidman (co-founders, chief medical officers, and internationally renowned IVF specialists), lead AiVF in developing an AI-based platform which optimizes the IVF journey for people seeking Assisted Reproductive Technologies. Advanced machine learning algorithms and computer vision algorithms could reduce time to conception and improve IVF predictability.

The platform is now available in Europe and Asia after three years of intensive research and development. AiVF expects rapid deployment of the platform as fertility clinics seek to use second-generation IVF technology to improve IVF care.



Leave a Comment